Dec 22, 2008 - NovaDel Pharma Inc. today announced that Zolpimist (zolpidem tartrate) 5 mg and 10 mg Oral Spray has been approved by the U.S. Food and Drug Administration (FDA) for the short-term treatment of insomnia characterized by difficulties with sleep initiation.
The details can be read here.
No comments:
Post a Comment